Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014265
Filing Date
2024-11-04
Accepted
2024-11-04 16:15:52
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q enfn-20240930x10q.htm   iXBRL 10-Q 1922950
2 EX-31.1 enfn-20240930xex31d1.htm EX-31.1 12462
3 EX-31.2 enfn-20240930xex31d2.htm EX-31.2 11710
4 EX-32.1 enfn-20240930xex32d1.htm EX-32.1 5046
5 EX-32.2 enfn-20240930xex32d2.htm EX-32.2 5055
  Complete submission text file 0001558370-24-014265.txt   6602892

Data Files

Seq Description Document Type Size
6 EX-101.SCH enfn-20240930.xsd EX-101.SCH 36461
7 EX-101.CAL enfn-20240930_cal.xml EX-101.CAL 49272
8 EX-101.DEF enfn-20240930_def.xml EX-101.DEF 177918
9 EX-101.LAB enfn-20240930_lab.xml EX-101.LAB 360146
10 EX-101.PRE enfn-20240930_pre.xml EX-101.PRE 265708
66 EXTRACTED XBRL INSTANCE DOCUMENT enfn-20240930x10q_htm.xml XML 1019307
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40949 | Film No.: 241423760
SIC: 7372 Services-Prepackaged Software
(CF Office: 06 Technology)